SMID vs. CORT
SMID (Smith-Midland Corporation) and CORT (Corcept Therapeutics Incorporated) are both stocks. SMID operates in Building Materials (Basic Materials), while CORT operates in Biotechnology (Healthcare). Over the past 10 years, SMID returned 28.70%/yr vs 29.31%/yr for CORT. At a 0.10 correlation, their price movements are largely independent.
Performance
SMID vs. CORT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SMID achieves a -15.16% return, which is significantly lower than CORT's 115.20% return. Both investments have delivered pretty close results over the past 10 years, with SMID having a 28.70% annualized return and CORT not far ahead at 29.31%.
SMID
- 1D
- 2.94%
- 1M
- -11.02%
- YTD
- -15.16%
- 6M
- -9.51%
- 1Y
- 5.11%
- 3Y*
- 20.27%
- 5Y*
- 12.19%
- 10Y*
- 28.70%
CORT
- 1D
- 3.08%
- 1M
- 45.90%
- YTD
- 115.20%
- 6M
- -11.54%
- 1Y
- 7.02%
- 3Y*
- 47.73%
- 5Y*
- 28.46%
- 10Y*
- 29.31%
SMID vs. CORT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SMID Smith-Midland Corporation | -15.16% | -18.26% | 12.56% | 92.68% | -56.38% | 397.35% | 57.50% | -18.98% | 9.99% | 29.02% |
CORT Corcept Therapeutics Incorporated | 115.20% | -30.94% | 55.14% | 59.92% | 2.58% | -24.31% | 116.20% | -9.43% | -26.02% | 148.76% |
Correlation
The correlation between SMID and CORT is 0.10, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.10 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.13 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.15 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.10 |
Correlation (All Time) Calculated using the full available price history since Jan 5, 2016 | 0.10 |
Fundamentals
SMID:
$3.54
CORT:
$0.41
SMID:
8.72
CORT:
182.61
SMID:
0.04
CORT:
90.97
SMID:
1.17
CORT:
11.30
SMID:
$93.45M
CORT:
$769.10M
SMID:
$26.04M
CORT:
$755.64M
SMID:
$19.01M
CORT:
$3.66M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SMID vs. CORT — Risk / Return Rank
SMID
CORT
SMID vs. CORT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Smith-Midland Corporation (SMID) and Corcept Therapeutics Incorporated (CORT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| SMID | CORT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.01 | ||
| Sortino ratioReturn per unit of downside risk | -0.17 | ||
| Omega ratioGain probability vs. loss probability | 1.06 | 1.14 | -0.08 |
| Calmar ratioReturn relative to maximum drawdown | 0.13 | 0.11 | +0.02 |
| Martin ratioReturn relative to average drawdown | 0.28 | 0.20 | +0.08 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| SMID | CORT | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.10 | 0.09 | +0.01 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.19 | 0.38 | -0.19 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.54 | 0.44 | +0.10 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.47 | 0.11 | +0.35 |
Drawdowns
SMID vs. CORT - Drawdown Comparison
The maximum SMID drawdown since its inception was -72.37%, smaller than the maximum CORT drawdown of -94.28%. Use the drawdown chart below to compare losses from any high point for SMID and CORT.
Loading charts...
Drawdown Indicators
| SMID | CORT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -72.37% | -94.28% | +21.91% |
Max Drawdown (1Y)Largest decline over 1 year | -39.29% | -64.40% | +25.11% |
Max Drawdown (3Y)Largest decline over 3 years | -48.85% | -71.85% | +23.00% |
Max Drawdown (5Y)Largest decline over 5 years | -72.37% | -71.85% | -0.52% |
Max Drawdown (10Y)Largest decline over 10 years | -72.37% | -71.85% | -0.52% |
Current DrawdownCurrent decline from peak | -38.38% | -34.43% | -3.95% |
Average DrawdownAverage peak-to-trough decline | -27.51% | -53.45% | +25.94% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 18.26% | 35.30% | -17.04% |
Volatility
SMID vs. CORT - Volatility Comparison
Smith-Midland Corporation (SMID) has a higher volatility of 16.95% compared to Corcept Therapeutics Incorporated (CORT) at 16.12%. This indicates that SMID's price experiences larger fluctuations and is considered to be riskier than CORT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SMID | CORT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.95% | 16.12% | +0.83% |
Volatility (6M)Calculated over the trailing 6-month period | 39.15% | 85.09% | -45.94% |
Volatility (1Y)Calculated over the trailing 1-year period | 52.88% | 76.52% | -23.64% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 64.79% | 74.51% | -9.72% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 54.16% | 67.19% | -13.03% |
Dividends
SMID vs. CORT - Dividend Comparison
Neither SMID nor CORT has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
CORT Corcept Therapeutics Incorporated | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SMID Smith-Midland Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.92% | 0.74% | 0.73% | 0.19% |
Financials
SMID vs. CORT - Financials Comparison
This section allows you to compare key financial metrics between Smith-Midland Corporation and Corcept Therapeutics Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
SMID vs. CORT - Profitability Comparison
SMID - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Smith-Midland Corporation reported a gross profit of 5.52M and revenue of 23.11M. Therefore, the gross margin over that period was 23.9%.
CORT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Corcept Therapeutics Incorporated reported a gross profit of 162.02M and revenue of 164.90M. Therefore, the gross margin over that period was 98.3%.
SMID - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Smith-Midland Corporation reported an operating income of 3.24M and revenue of 23.11M, resulting in an operating margin of 14.0%.
CORT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Corcept Therapeutics Incorporated reported an operating income of -49.60M and revenue of 164.90M, resulting in an operating margin of -30.1%.
SMID - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Smith-Midland Corporation reported a net income of 2.13M and revenue of 23.11M, resulting in a net margin of 9.2%.
CORT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Corcept Therapeutics Incorporated reported a net income of -31.20M and revenue of 164.90M, resulting in a net margin of -18.9%.
Frequently Asked Questions
SMID and CORT have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SMID has higher volatility (16.95%) compared to CORT (16.12%). In terms of maximum drawdown, SMID dropped -72.37% vs CORT's -94.28%.
SMID currently has the higher Sharpe Ratio (0.10 vs 0.09), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SMID and CORT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer